Corticosteroids delay remyelination of experimental demyelination in the rodent central nervous system

Journal of Neuroscience Research

Volumn 83, Issue 4, 2006, Pages 594-605

  Chari, Divya M ^a,b   Zhao, Chao ^a   Kotter, Mark R ^a   Blakemore, William F ^a   Franklin, Robin J M ^a  

^a UNIVERSITY OF CAMBRIDGE   (United Kingdom)

^b UNIVERSITY OF CAMBRIDGE   (United Kingdom)

Author keywords

Corticosteroids; Demyelination; Multiple sclerosis; Oligodendrocyte progenitors; Remyelination

Indexed keywords

CORTICOSTEROID; METHYLPREDNISOLONE SODIUM SUCCINATE; PREDNISONE; TOXIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL REGENERATION; CENTRAL NERVOUS SYSTEM DISEASE; CONTROLLED STUDY; DEMYELINATION; DOSE RESPONSE; FEMALE; MULTIPLE SCLEROSIS; NERVE CELL DIFFERENTIATION; NONHUMAN; OLIGODENDROGLIA; PRIORITY JOURNAL; RAT; REMYELINIZATION; SCHWANN CELL; SPINAL CORD DISEASE; STEM CELL;

ADRENAL CORTEX HORMONES; ANIMALS; CENTRAL NERVOUS SYSTEM; DEMYELINATING DISEASES; ETHIDIUM; FEMALE; GLIAL FIBRILLARY ACIDIC PROTEIN; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; MACROPHAGES; MYELIN SHEATH; OLIGODENDROGLIA; PHAGOCYTOSIS; RATS; STEM CELLS;

EID: 33644931322     PISSN: 03604012     EISSN: 10974547     Source Type: Journal    
DOI: 10.1002/jnr.20763     Document Type: Article

References (71)

1. Alonso G. 2000. Prolonged corticosterone treatment of adult rats inhibits the proliferation of oligodendrocyte progenitors present throughout white and grey matter regions of the brain. Glia 31:219-231.
2. Arnett HA, Mason J, Marino M, Suzuki K, Matsushima GK, Ting JP. 2001. TNF alpha promotes proliferation of oligodendrocyte progenitors and remyelination. Nat Neurosci 4:1116-1122.
3. Arnett HA, Wang Y, Matsushima GK, Suzuki K, Ting JP. 2003. Functional genomic analysis of remyelination reveals importance of inflammation in oligodendrocyte regeneration. J Neurosci 23:9824-9832.
4. Ayers MM, Hazelwood LJ, Catmull DV, Wang D, McKormack Q, Bernard CC, Orian JM. 2004. Early glial responses in murine models of multiple sclerosis. Neurochem Int 45:409-419.
5. Barres BA, Lazar MA, Raff MC. 1994. A novel role for thyroid hormone, glucocorticoids and retinoic acid in timing oligodendrocyte development. Development 120:1097-1108.
6. Bieber AJ, Kerr S, Rodriguez M. 2003. Efficient central nervous system remyelination requires T cells. Ann Neurol 53:680-684.
7. Blakemore WF. 2005. The case for a central nervous system (CNS) origin for the Schwann cells that remyelinate CNS axons following concurrent loss of oligodendrocytes and astrocytes. Neuropathol Appl Neurobiol 31:1-10.
8. Blakemore WF, Chari DM, Gilson JM, Crang AJ. 2002. Modelling large areas of demyelination in the rat reveals the potential and possible limitations of transplanted glial cells for remyelination in the CNS. Glia 38:155-168.
9. Blakemore WF, Gilson JM, Crang AJ. 2003. The presence of astrocytes in areas of demyelination influences remyelination following transplantation of oligodendrocyte progenitors. Exp Neurol 184:955-963.
10. Bohn MC, Friedrich VL. 1982. Recovery of myelination in rat optic nerve after developmental retardation by cortisol. J Neurosci 2:1292-1298.
11. Byravan S, Campagnoni AT. 1994. Serum factors and hydrocortisone influence the synthesis of myelin basic proteins in mouse brain primary cultures. Int J Dev Neurosci 12:343-351.
12. Byravan S, Foster LM, Phan T, Verity AN, Campagnoni AT. 1994. Murine oligodendroglial cells express nerve growth factor. Proc Natl Acad Sci USA 91:8812-8816.
13. Chan JR, Phillips LJ 2nd, Glaser M. 1998. Glucocorticoids and progestins signal the initiation and enhance the rate of myelin formation. Proc Natl Acad Sci USA 95:10459-10464.
14. Edgar JM, McLaughlin M, Yool D, Zhang SC, Fowler JH, Montague P, Barrie JA, McCulloch MC, Duncan ID, Garbern J, Nave KA, Griffiths IR. 2004. Oligodendroglial modulation of fast axonal transport in a mouse model of hereditary spastic paraplegia. J Cell Biol 166:121-131.
15. Feldhaus B, Dietzel ID, Heumann R, Berger B. 2004. Corticoids protect oligodendrocyte precursor cells against cytokine-induced damage. Zentralbl Gynakol 126:282-285.
16. Ferguson B, Matyszak MK, Esiri MM, Perry VH. 1997. Axonal damage in multiple sclerosis lesions. Brain 120:393-399.
17. Franklin RJM. 1999. Remyelination-a regenerative process in the CNS. Neuroscientist 5:184-191.
18. Franklin RJM. 2002. Why does remyelination fail in multiple sclerosis? Nat Rev Neurosci 3:705-714.
19. Franklin RJM, Crang AJ, Blakemore WF. 1991. Transplanted type-1 astrocytes facilitate repair of demyelinating lesions by host oligodendrocytes in adult rat spinal cord. J Neurocytol 20:420-430.
20. Frost EE, Nielsen JA, Le TQ, Armstrong RC. 2003. PDGF and FGF2 regulate oligodendrocyte progenitor responses to demyelination. J Neurobiol 54:457-472.
21. Garbern JY, Yool DA, Moore GJ, Wilds IB, Faulk MW, Klugmann M, Nave KA, Sistermans EA, van der Knaap MS, Bird TD, Shy ME, Kamholz JA, Griffiths IR. 2002. Patients lacking the major CNS myelin protein, proteolipid protein 1, develop length-dependent axonal degeneration in the absence of demyelination and inflammation. Brain 125:551-561.
22. Gensert JM, Goldman JE. 1997. Endogenous progenitors remyelinate demyelinated axons in the adult CNS. Neuron 9:197-203.
23. Glezer I, Rivest S. 2004. Glucocorticoids: protectors of the brain during innate immune responses. Neuroscientist 10:538-552.
24. Gonzalez-Perez O, Ramos-Remus C, Garcia-Estrada J, Luquin S. 2001. Prednisone induces anxiety and glial cerebral changes in rats. J Rheumatol 28:2529-2534.
25. Graca DL, Blakemore WF. 1986. Delayed remyelination in the rat spinal cord following ethidium bromide injection. Neuropathol Appl Neurobiol 12:593-605.
26. Griffiths I, Klugmann M, Anderson T, Yool D, Thomson C, Schwab MH, Schneider A, Zimmermann F, McCulloch M, Nadon N, Nave KA. 1998. Axonal swellings and degeneration in mice lacking the major proteolipid of myelin. Science 280:1610-1613.
27. Halfpenny CA, Scolding NJ. 2003. Immune-modifying agents do not impair the survival, migration or proliferation of oligodendrocyte progenitors (CG-4) in vitro. J Neuroimmunol 139:9-16.
28. Han J, Hajjar DP, Febbraio M, Nicholson AC. 1997. Native and modified low density lipoproteins increase the functional expression of the macrophage class B scavenger receptor, CD36. J Biol Chem 272: 21654-21659.
29. Hemmer B, Archelos JJ, Hartung HP. 2002. New concepts in the immunopathogenesis of multiple sclerosis. Nat Rev Neurosci 3:291-301.
30. Hinks GL, Franklin RJM. 1999. Distinctive patterns of PDGF-A, FGF-2, IGF-I, and TGF-beta1 gene expression during remyelination of experimentally-induced spinal cord demyelination. Mol Cell Neurosci 14:153-168.
31. Hinks GL, Franklin RJM. 2000. Delayed changes in growth factor gene expression during slow remyelination in the CNS of aged rats. Mol Cell Neurosci 16:542-556.
32. Huang WL, Harper CG, Evans SF, Newnham JP, Dunlop SA. 2001. Repeated prenatal corticosteroid administration delays myelination of the corpus callosum in fetal sheep. Int J Dev Neurosci 19:415-425.
33. Husemann J, Loike JD, Anankov R, Febbraio M, Silverstein SC. 2002. Scavenger receptors in neurobiology and neuropathology: their role on microglia and other cells of the nervous system. Glia 40:195-205.
34. Husemann J, Silverstein SC. 2001. Expression of scavenger receptor class B, type 1, by astrocytes and vascular smooth muscle cells in normal adult mouse and human brain and in Alzheimer's diseased brain. Am J Pathol 158:825-832.
35. Jacobs SC, Bootsma AL, Willems PW, Bar PR, Wokke JH. 1996. Prednisone can protect against exercise-induced muscle damage. J Neurol 243:410-416.
36. Jeffery ND, Blakemore WF. 1997. Locomotor deficits induced by experimental spinal cord demyelination are abolished by spontaneous remyelination. Brain 120:27-37.
37. Keegan BM, Noseworthy JH. 2002. Multiple sclerosis. Annu Rev Med 53:285-302.
38. Kornek B, Storch MK, Weissert R, Wallstroem E, Stefferl A, Olsson T, Linington C, Schmidbauer M, Lassmann H. 2000. Multiple sclerosis and chronic autoimmune encephalomyelitis: a comparative quantitative study of axonal injury in active, inactive, and remyelinated lesions. Am J Pathol 157:267-276.
39. Kotter MR, Setzu A, Sim FJ, Van Rooijen N, Franklin RJM. 2001. Macrophage depletion impairs oligodendrocyte remyelination following lysolecithin-induced demyelination. Glia 35:204-212.
40. Kotter MR, Zhao C, van Rooijen N, Franklin RJM. 2005. Macrophage-depletion induced impairment of experimental CNS remyelination is associated with a reduced oligodendrocyte progenitor cell response and altered growth factor expression. Neurobiol Dis 18:166-175.
41. Lassmann H, Bruck W, Lucchinetti C, Rodriguez M. 1997. Remyelination in multiple sclerosis. Mult Scler 3:133-136.
42. Leussink VI, Jung S, Merschdorf U, Toyka KV, Gold R. 2001. High dose methylprednisolone therapy induces apoptosis in peripheral blood leukocytes. Arch Neurol 58:91-97.
43. Levine JM, Reynolds R. 1999. Activation and proliferation of endogenous oligodendrocyte precursor cells during ethidium bromide-induced demyelination. Exp Neurol 160:333-347.
44. Li WW, Setzu A, Zhao C, Franklin RJM. 2005. Minocycline-mediated inhibition of microglia activation impairs oligodendrocyte progenitor cell responses and remyelination in a non-immune model of demyelination. J Neuroimmunol 158:58-66.
45. Long JB, Holaday JW. 1985. Blood-brain barrier: endogenous modulation by adrenal-cortical function. Science 29:1580-1583.
46. Lovas G, Szilagyi N, Majtenyi K, Palkovits M, Komoly S. 2000. Axonal changes in chronically demyelinated cervical spinal cord plaques. Brain 123:308-317.
47. Ludwin SK. 1980. Chronic demyelination inhibits remyelination in the central nervous system. Lab Invest 43:382-387.
48. Mason JL, Suzuki K, Chaplin DD, Matsushima GK. 2001. Interleukin-1beta promotes repair of the CNS. J Neurosci 21:7046-7052.
49. Melcangi RC, Cavaretta I, Magnaghi V, Ciusani E, Salmaggi A. 2000. Corticosteroids protect oligodendrocytes from cytokine induced cell death. Neuroreport 11:3969-3972.
50. Miller DH, Thompson AG, Morrissey SP, MacManus DG, Moore SG, Kendall BE, Moseley IF, McDonald WI. 1992. High dose steroids in acute relapses of multiple sclerosis: MRI evidence for a possible mechanism of therapeutic effects. J Neurol Neurosurg Psychiatry 55:450-453.
51. Neuberger TJ, Kalimi O, Regelson W, Kalimi M, De Vries GH. 1994. Glucocorticoids enhance the potency of Schwann cell mitogens. J Neurosci Res 15:300-313.
52. Pavelko KD, van Engelen BG, Rodriguez M. 1998. Acceleration in the rate of CNS remyelination in lysolecithin-induced demyelination. J Neurosci 18:2498-2505.
53. Poduslo SE, Pak CH, Miller K. 1990. Hydrocortisone induction during oligodendroglial differentiation. Neurosci Lett 113:84-88.
54. Prineas JW, Barnard RO, Kwon EE, Sharer LR, Cho ES. 1993. Multiple sclerosis: remyelination of nascent lesions. Ann Neurol 33:137-151.
55. Prineas JW, Connell F. 1979. Remyelination in multiple sclerosis. Ann Neurol 5:22-31.
56. Quinlivan JA, Beazley LD, Archer M, Beazley LD, Newnham JP. 1997. Repeated prenatal corticosteroids delay myelination in the ovine central nervous system. J Matern Fetal Med 6:309-313.
57. Raine CS, Wu E. 1993. Multiple sclerosis: remyelination in acute lesions. J Neuropathol Exp Neurol 52:199-204.
58. Redwine JM, Armstrong RC. 1998. In vivo proliferation of oligodendrocyte progenitors expressing PDGF alphaR during early remyelination. J Neurobiol 37:413-428.
59. Rodriguez M, Lindsley MD. 1992. Immunosuppression promotes CNS remyelination in chronic virus-induced demyelinating disease. Neurology 42:348-357.
60. Rosner M, Lam TT, Fu J, Tso MO. 1992. Methylprednisolone ameliorates retinal photic injury in rats. Arch Ophthalmol 110:857-861.
61. Russo-Marie F. 1992. Macrophages and the glucocorticoids. J Neuroimmunol 40:281-286.
62. Sim FJ, Zhao C, Li WW, Lakatos A, Franklin RJM. 2002. Expression of the POU-domain transcription factors SCIP/Oct-6 and Brn-2 is associated with Schwann cell but not oligodendrocyte remyelination of the CNS. Mol Cell Neurosci 20:669-682.
63. Smith KJ, Blakemore WF, McDonald WI. 1979. Central remyelination restores secure conduction. Nature 280:395-396.
64. Smith PM, Franklin RJM. 2001. The effect of immunosuppressive protocols on spontaneous CNS remyelination following toxin-induced demyelination. J Neuroimmunol 119:261-268.
65. Trapp BD, Peterson J, Ransohoff RM, Rudick R. 1998. Axonal transection in the lesions of multiple sclerosis. N Engl J Med 338:278-285.
66. Triarhou LC, Herndon RM. 1986, The effect of dexamethasone on L-alpha-lysophosphatidyl choline (lysolecithin)-induced demyelination of the rat spinal cord. Arch Neurol 43:121-125.
67. Warringa RA, Hoeben RC, Koper JW, Sykes JE, van Golde LM, Lopes-Cardozo M. 1987. Hydrocortisone stimulates the development of oligodendrocytes in primary glial cultures and affects glucose metabolism and lipid synthesis in these cultures. Brain Res 431:79-86.
68. Watanabe M, Toyama Y, Nishiyama A. 2002. Differentiation of proliferated NG2-positive glial progenitor cells in a remyelinating lesion. J Neurosci Res 69:826-836.
69. Wilkins A, Majed H, Layfield R, Compston A, Chandran S. 2003. Oligodendrocytes promote neuronal survival and axonal length by distinct intracellular mechanisms: a novel role for oligodendrocyte-derived glial cell line-derived neurotrophic factor. J Neurosci 23:4967-4974.
70. Zhao C, Li WW, Franklin RJM. 2006. Differences in the early inflammatory responses to toxin induced demyelination are associated with age related decline in CNS remyelination. Neurobiol Aging (in press).
71. Zivadinov R, Rudick RA, De Masi R, Nasuelli D, Ukmar M, Pozzi-Mucelli RS, Grop A, Cazzato G, Zorzon M. 2001. Effects of IV methylprednisolone on brain atrophy in relapsing-remitting MS. Neurology 57:1239-1247.